TRANSCENTA HOLDING LIMITED

Insiders Transcenta Holding Limited

Equities

6628

KYG9005B1041

Delayed Hong Kong S.E. Other stock markets 03:29:12 26/06/2024 BST			5-day change	1st Jan Change
1.43 ^HKD	0.00%		+6.72%	-60.17%

06-07	Transcenta Holding Limited commences an Equity Buyback Plan for 43,637,537 shares, representing 10% of its issued share capital, under the authorization approved on June 7, 2024.	CI
06-07	Transcenta Holding Limited Announces Directorate and Board Changes	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Transcenta Holding Limited Announces Directorate and Board Changes	06-07	CI
Transcenta Holding Limited Announces Board and Nomination Changes	04-30	CI
Transcenta Holding Limited Announces Management Changes, Effective August 23, 2023	22/08/23	CI
Transcenta Holding Limited Announces Appointment of Independent Non-Executive Director and Change in the Composition of Board Committees	19/12/22	CI
Transcenta Hires Former AstraZeneca Exec as New Chief Medical Officer	08/08/22	MT
Transcenta Holding Limited Announces the Appointment of Caroline Germa as Executive Vice President, Global Medicine Development and Chief Medical Officer	07/08/22	CI
Transcenta Holding Limited Announces Change of the Chief Medical Officer	02/08/22	CI
Transcenta Holding Limited Announces Resignation of Michael Ming Shi as Executive Director	20/07/22	CI
Transcenta Holding Limited Announces Demise of Albert Da Zhu, an Executive Director and a Joint Company Secretary	27/06/22	CI
Transcenta Holding Limited Announces Executive Changes	21/03/22	CI
Transcenta Hires Former CStone Pharma Exec as CFO	17/12/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer